Skip to main content
Premium Trial:

Request an Annual Quote

Molecula Moves to New Virginia Facility

NEW YORK, June 17 (GenomeWeb News) - Oligo manufacturer Molecula has moved into a new facility in Sterling, Va., its parent company CalbaTech said today.


The new facility will enable Molecula to become a fully compliant cGMP oligo manufacturer of siRNA and other oligo products, according to the company.


Molecula was founded in 1993 as a provider of antisense oligonucleotides. Its current product portfolio includes custom oligos, peptide services, and transfection agents.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.